Top news of the week: 29.12.2020.
Startups
Meet The 50 Doctors, Scientists And Healthcare Entrepreneurs Who Became Pandemic Billionaires In 2020
A surge in healthcare stocks has minted more than four dozen new billionaires from just that sector this year, driven largely by the impact of the Covid-19 pandemic.
The Massachusetts Miracle is alive and well. ‘There are a lot of potential Modernas’
The spotlight may be on Moderna — the Cambridge biotechnology company that is harnessing messenger RNA to inoculate millions — but it is far from the only local company that will likely ...
Forbes Biotech & Pharma Awards 2020: Here Comes The Vaccine Bonanza
Faced with a once-in-a-century pandemic, biotech and pharma companies stepped up to the plate in a major way. Here are the best products, most intriguing people and most exciting trends of ...
A top biotech venture capitalist saw the pandemic coming. He shared his prediction for how the coronavirus will shape 2021.
"2021 is going to feel like we're pulling out of it, but we're not going to be all the way out," ARCH Venture Partners' Robert Nelsen said.
How 2020 became the year of the biotech SPAC
In 2020, 33 health care-focused blank-check firms have gone public, raising $6.3 billion from investors this year.
Healthcare VCs share their 2021 predictions
These are Business Insider's biggest healthcare stories for December 22.
A big year in biotech was a windfall for top IPO lawyers laser-focused on the space
The 2020 IPO market saw a slowdown in March and a frenzy of deals in December. Biotech brought steady capital markets work to life sciences lawyers.
Moderna’s Vaccine Is A Startup Triumph, Too
An interview with Noubar Afeyan, co-founder and chairman of Moderna, about the timeline of the company's remarkable 'from outrageous, to obvious, to lifesaving' accomplishment.